Adagio Medical Holdings, Inc. (ADGM) director receives 90,000 stock options

Rhea-AI Filing Summary

Adagio Medical Holdings, Inc. reported that a director acquired a non-qualified stock option to purchase 90,000 shares of common stock on 12/11/2025 at an exercise price of $0.8779 per share.

The option expires on 12/10/2035 and is held directly. The shares underlying the option will vest in 36 equal monthly installments starting January 11, 2026, subject to the director continuing to provide services on each vesting date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Salmon Sean

(Last) (First) (Middle)

C/O ADAGIO MEDICAL HOLDINGS, INC.

26051 MERIT CIRCLE, SUITE 102

(Street)

LAGUNA HILLS CA 92653

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Adagio Medical Holdings, Inc. [ ADGM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified stock option (right to buy)(1)	$0.8779	12/11/2025		A		90,000		(1)	12/10/2035	Common Stock	90,000	$0	90,000	D

Explanation of Responses:

1. The shares subject to the option will vest in 36 equal monthly installments commencing on January 11, 2026, subject to the Reporting Person's continued services through each such date.

	/s/ Deborah Kaster, Attorney-in-Fact	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Adagio Medical Holdings, Inc. (ADGM) report in this Form 4?

The filing reports that a director acquired a non-qualified stock option90,000 shares of Adagio Medical Holdings, Inc. common stock.

How many ADGM stock options were granted and at what exercise price?

The director received 90,000 non-qualified stock options with an exercise price of $0.8779 per share.

When do the reported ADGM stock options vest?

The shares underlying the option vest in 36 equal monthly installments beginning on January 11, 2026, subject to the director’s continued service on each vesting date.

When do the Adagio Medical (ADGM) stock options reported here expire?

The non-qualified stock option reported in this filing has an expiration date of 12/10/2035.

What is the reporting person’s relationship to Adagio Medical Holdings, Inc. (ADGM)?

The relationship section indicates that the reporting person is a director of Adagio Medical Holdings, Inc.

Are the ADGM options held directly or indirectly by the reporting person?

The filing shows the ownership form as Direct (D), meaning the options are held directly by the reporting person.